[Radiochemotherapy in the treatment of metastatic renal cell carcinoma].
Enhancement of the radiation effect with Epirubicin (20 mg day 1 to 5 and 29 to 33) in a metastasis of a renal cell carcinoma will be presented. The published experimental results are also encouraging.
Strnad
V
V
Klinik und Poliklinik für Strahlentherapie, Universität Erlangen-Nürnberg.
Senft
M
M
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary*; D003131:Combined Modality Therapy; D015251:Epirubicin / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D008297:Male
D015251:Epirubicin
Radiochemotherapie in der Behandlung des metastasierenden Nierenzellkarzinoms.